
FORW.PHARMA ADR/14
Depository Receipt · US34986J2042 · FWP · A2PV5H (XNCM)
No Price
n/a
Company Profile for FORW.PHARMA ADR/14 Depository Receipt
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Company Data
Name FORW.PHARMA ADR/14
Company Forward Pharma A/S
Symbol FWP
Website
https://www.forward-pharma.com
Primary Exchange
NASDAQ CAPITAL MARKET
WKN A2PV5H
ISIN US34986J2042
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Claus Svendsen
Country Denmark
Currency EUR
Employees 0,0 T
Address Oestergade 24A, 1, Copenhagen K, 1100 Koebenhavn K
IPO Date 2014-10-15
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | FWP |
More Shares
Investors who hold FORW.PHARMA ADR/14 also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.




